NEW YORK--(BUSINESS WIRE)--INNOVIVE Pharmaceuticals, Inc. (OTCBB: IVPH), a biopharmaceutical company that acquires, develops, and commercializes novel oncology and hematology therapeutics, today reported results for the three and nine months ended September 30, 2006.
